This content is from: Transfer Pricing

Merck Group’s Frank Schoeneborn on patent boxes, people functions and profit splits

Frank Schoeneborn, head of operational transfer pricing at Merck Group, shares his views on BEPS progress, issues of confidentiality and the increasingly negative press transfer pricing is receiving.

To access our market-driven intelligence please request a trial here.

Read this article – and more – for a one-week period.

REQUEST ACCESS

Are you already an ITR subscriber? Log in here

Instant access to all of our content. Membership Options | One Week Trial

Related